Journal of Cancer Survivorship · 18 Nov 2026
Co-design and feasibility of an mHealth survivorship program for colorectal cancer survivors: a mix-methods study
Pham Nhat Vi Do, Van Kha Vo, Thi Huong Ly Tran, Que Tran Nguyen, Yuen Tung Lam, Thi Khanh Nguyen, Thi Nhi Vo, Shishuang Zhou, Cho Lee Wongh-index 25
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Purpose Colorectal cancer (CRC) survivors experience persistent challenges that negatively affect health-related quality of life (HRQoL). While mobile health (mHealth) may offer a useful approach to survivorship care, limited user involvement and scarcity of structured programs in developing countries remain barriers. This study aimed to co-design and evaluate the feasibility of an mHealth survivorship program for CRC survivors following primary treatment. Methods A mixed-methods study was conducted in two phases. Phase 1 utilized a user-centered design framework involving 12 co-designers across nine online sessions to develop and refine the FORYOU mHealth program. Phase 2 was a pilot randomized controlled trial (RCT) with 30 CRC survivors to assess feasibility and preliminary effectiveness of the 12-week program, measured by HRQoL outcomes. Results In phase 1, the co-designed program indicated above-average usability (System Usability Scale ≥ 68) and adequate acceptability (E-Acceptability Scale ≥ 24). In phase 2, the adherence rate was 73.3%; participants in the intervention group completed an average of 5.4 out of 6 sessions and accessed the app 9.7 times. Although no significant between-group difference was observed in overall HRQoL, exploratory findings were mixed. The intervention favored the subscale functional well-being ( P < 0.05; g = 1.34), whereas the control group favored the secondary outcome, fatigue. These preliminary findings require cautious interpretation. Conclusion The co-designed mHealth program was usable and acceptable, and the pilot RCT was feasible among CRC survivors after primary treatment. Exploratory findings suggested possible benefits in selected outcomes, but these preliminary findings require confirmation in a larger adequately powered trial. Implications for Cancer Survivors This co-designed mHealth survivorship program showed encouraging engagement among CRC survivors after primary treatment, with exploratory findings suggesting potential effects on selected survivorship outcomes. Trial registration NCT07158671 on ClinicalTrials.gov. Registered on September 8, 2025
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Cho Lee Wong has the highest h-index among the authors (25).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (68)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 48 more references
A free account opens the rest of the citing papers and references on every paper’s page.